Sun Pharma Signs US Government Deal to Supply Medicines at Lower Prices

India’s largest drugmaker, Sun Pharmaceutical Industries, has signed an agreement with the US government to make medicines more affordable for American patients. Under the deal, the Mumbai-based pharmaceutical major will offer “Most Favoured Nation” pricing to state Medicaid programmes across the United States.

The agreement is aimed at reducing the cost of prescription medicines for eligible beneficiaries and improving access to essential treatments. Sun Pharma’s participation comes amid growing efforts by the US administration to negotiate lower drug prices and expand affordable healthcare access.The deal is expected to strengthen Sun Pharma’s presence in the US pharmaceutical market while supporting the broader push to make medicines more accessible and affordable for American consumers.